Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00309907 · OUTCOME

Toxicity of Etanercept Plus Corticosteroid Therapy Using the Common Terminology Criteria Version 4.0

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant · Source last updated 2017-09-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Patients
Interval / dispersion
Not reported
Time frame
Up to 56 days

What was measured

Grade 3-5 organ toxicities attributable to etanercept.

Analysis population: 28 patients evaluable for this outcome.

Groups in this outcome

Etanercept and Corticosteroid Therapy

Regimen A

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy28

Reported measurements

Source class 1
Values in Patients · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
denoms
  1. counts
    1. group Id
      OG000
      value
      28
    units
    Participants
description
Grade 3-5 organ toxicities attributable to etanercept.
groups
  1. description
    Regimen A
    id
    OG000
    title
    Etanercept and Corticosteroid Therapy
param Type
NUMBER
population Description
28 patients evaluable for this outcome.
reporting Status
POSTED
time Frame
Up to 56 days
title
Toxicity of Etanercept Plus Corticosteroid Therapy Using the Common Terminology Criteria Version 4.0
type
SECONDARY
unit Of Measure
Patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice